MyBrainTech MyBrainTech MyBrainTech
  • How myBrain works
  • Who we are
  • Want to learn more
  • Contact Us
  • How myBrain works
  • Who we are
  • Want to learn more
  • Contact Us

The path to ISO 13485.

8 juillet 2021 | 2 mins read

  • Articles

By Sophie Colliot, Quality Manager at myBrain Technologies.

Illustration by myBrain Technologies

Implementing a quality approach within a start-up poses particular difficulties linked to the context of innovation, agility and rapid growth. However, such an approach is essential to guarantee the sustainability of its activities and to enable it to become a leader in its market.

Report.

On June 2, 2021, myBrain Technologies obtains the ISO 13485 certificate (Medical devices – Quality management systems – Requirements for regulatory purposes). The entire team is very proud of this. The publication of the ISO 13485 certificate is synonymous with easier access to the market of safe and efficient medical devices, but it also means for us the concretization of 5 years of beautiful, rich and intense experiences from an organizational and human perspective.

Illustration by myBrain Technologies

Launch.

The quality process was initiated in 2016 at myBrain Technologies, only two years after its creation, and following the completion of my second university degree « Managing Quality » in Specialized Master (ENSAM, Paris). As quality does not have a very good reputation in the startup world, it was necessary to transmit its strong points but also to adapt, innovate and advance step by step with the collaborators by training them, some of them having never had any experience in the medical field. The management team has always supported the quality process: it has appointed the pilots in a management review and set ambitious quality objectives. My role consisted first of all in establishing a relationship of trust with our service providers, our notified body BSI, as well as an ecosystem of internal and external skills to achieve our quality objectives.

Impact.

The quality process has had several positive impacts during its implementation. On the one hand, the « open » quality management system (QMS)[1] has facilitated the market access of melomind, a connected audio EEG device now marketed to learn how to manage one’s state of relaxation via the neurofeedback principle. On the other hand, it served as a springboard to develop our medical activity with the deployment of ISO 13485. 

Methodology.

Today, we manage a totally dematerialized ISO 13485 QMS thanks to digital tools, which is a great advantage in the context of the health crisis: the first certification audits had to be conducted remotely. This specificity continues to be an advantage, since we can manage and improve our QMS remotely by maintaining a flexible organization in telecommuting.

Perspectives.

Our ISO 13485 process is conducted in parallel with the CE marking process according to the medical device regulation. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on Medical Devices (MDR) came into force on 25 May 2017 and came into effect on 26 May 2021 following the amending regulation (EU) 2020/561, i.e. 1 year later than initially planned. Our medical devices will be CE marked under the new MDR. BSI is one of the first organizations to be notified under the regulation. The marking of our medical devices is in progress with the collaboration of the whole team for the constitution of the technical file.

References.

[1] Duffaure S., Maranzana N., Attal Y. & Duchamp R. (2017). Démarche qualité et start-up. Déploiement au sein d’une start-up dans le domaine de la santé et du bien-être. Conférence : 12ème Congrès International de Génie Industriel (CIGI’17), Compiègne, France, Mai 2017.

  • agility
  • growth
  • innovation
  • ISO 13485
  • medical devices
  • QMS

Next
14 septembre 2021
Computational Psychiatry: how neurotechnology is changing the world of mental health ?
Neuroscience and artificial intelligence are about to revolutionize medicine, especially psychiatry. Neurotechnologies offer a range of new tools based on objective and empirical data which will revolutionize the diagnosis and prevention of psychiatric pathologies.
Neuroscience and artificial intelligence are about to revolutionize medicine, especially psychiatry. Neurotechnologies offer a range of new tools based on objective and empirical data which will revolutionize the diagnosis and prevention of psychiatric pathologies.

Related articles

08 Juil 2021

The benefits of collecting EEG neuroimaging insights in clinical trials.

In clinical trials, brain monitoring EEG is facilitating the measurement of complex clinical endpoints. EEG as a biomarker provides safe, objective and repeatable data enabling a deeper understanding of the pharmacological effects of the drug early in its development.

08 Juil 2021

Newsletter | December 2022.

During this year of 2022, we have dedicated ourselves to make our solution more complete and ergonomic through many updates designed to optimize the way you realize your experiments. The end of the year is for us the opportunity to come back on the major improvements of our solution ...

08 Juil 2021

Newsletter | November 2022.

The end of 2022 marks a major step forward in the neurotechnology sector in France: the presentation of a Charter for a responsible development of neurotechnologies by the Ministry of Higher Education and Research. Directly concerned, myBrain Technologies wanted to participate ...

08 Juil 2021

A milestone for NeuroEthics.

The capacity of neurotechnologies to probe and interfere with brain activity challenges notions of identity, integrity and autonomy of human being. Recent initiatives aim to help actors in the field anticipate and address ethical, legal and social challenges, while promoting innovation in this area.

MyBrainTech
Copyright © 2022
All rights reserved
Legals notices
Privacy Policy
Cookie policy

Company

  • How myBrain works
  • Who we are
  • Want to learn more
  • Contact Us

E-Mail

innovate@mybraintech.com

Visit

50 Avenue Claude Vellefaux
75010 Paris

Subscribe to our newsletter

We use cookies to optimise our website and our service. Cookie Policy
Accept AllDismissPreferences
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Toujours activé
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDuréeDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDuréeDescription
WEBMO-MNOsessionNo description
Enregistrer & appliquer
Propulsé par CookieYes Logo
Get Your Free White Paper by Email

    I understand my submitted information will be used to help my request according myBrain Technologies. Discover the privacy policy.